The Myocardial Vasculature During Ischemia and Reperfusion: A Target for Injury and Protection

Journal of Molecular and Cellular Cardiology

Volumn 25, Issue 7, 1993, Pages 759-800

  Hearse, David J ^a   Maxwell, Linda ^b   Saldanha, Clyde ^a   Gavin, John B ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

"No flow" phenomenon; Cardiac surgery; Coronary perfusion; Ischemia; Microcirculation; Myocytes; Reperfusion; Thrombolysis; Vascular endothelium

Indexed keywords

BLOOD CLOT LYSIS; CORONARY ARTERY BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REVIEW; VASCULAR ENDOTHELIUM;

ANIMAL; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; RATS; REPERFUSION INJURY; SUPPORT, NON-U.S. GOV'T;

EID: 0027183768     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1993.1089     Document Type: Article

References (183)

1. Hearse D. J. Ischemia, reperfusion, and the determinants of tissue injury. Cardiovasc Drugs Thcrap 4, 767-776 (1990).
2. Hearse D. J., Bolli R. Reperfusion-induced injury: manifestations, mechanisms and clinical relevance. Cardiovasc Res 26, 101-108 (1992).
3. Manning A. S., Hearse D. J. Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 16, 497-518 (1984).
4. Hearse D, J. Stunning: a radical re-view. Cardiovasc Drugs Therap 5, 853-876 (1991).
5. Bolli R. Oxygen-derived free radicals and postisehemic myocardial dysfunction (“stunned myocardium”). J Am Coll Cardiol 12, 239-249 (1988).
6. Bolli R. Mechanism of myocardial “stunning”. Circulation 82, 723-738 (1990).
7. Braunwald E, Kloner R A. The stunned myocardium: prolonged, post-ischemic ventricular dysfunction. Circulation 66, 1146-1149 (1982).
8. Becker L C, Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 30, 23-44 (1987).
9. Pearson P. J., Sghafe H. V., Vanhoutte P. M. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res 67, 385-393 (1990).
10. Kloner R. A., Rude R. E., Carlson N C, et al. Ultrastructural evidence of microvascular damage and myocardial cell injury' after coronary artery occlusion: which comes lirsti* Circulation 62, 945-952 (1980).
11. Reimer K. A., Jennings R. B. Cellular ion and water shifts. In: Pathophysiology of shock, anoxia and ischemia, edited by Cowley, R. A. and Trump, B, F. Baltimore: Williams and Wilkins p. 132-147 (1982).
12. Tsao P S., Aoki, N., Lefer D. J., et al. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82, 1402-1412 (1990).
13. Maxwell L., Gavin R B, The role of postisehemic rcperfusion in the development of microvascular incompetence and ultrastructural damage in the myocardium. Bas Res Cardiol 86, 544-553 (1991).
14. Esters H E., Entman M. L., Dixon H. B., et al. The vascular supply of the left ventricular wall. Am Heart J 71, 58-67 (1966).
15. Farrer-Brown G, Normal and diseased vascular pattern of myocardium of human heart. 1. Normal pattern in the left ventricular free wall. Br Heart J 30, 527-536 (1968).
16. James T. N. The delivery and distribution of the coronary collateral circulation. Chest 58, 183-203 (1970).
17. Bloor C. M. Functional significance of the coronary collateral circulation: a review. Am J Path 76, 561-588 (1974).
18. James T. N. Circulation today: the coronary arteries. JAMA 239, 1302-1307 (1978).
19. Paster S. B. The coronary collaterals: then development, morphology, function and classification. CRG Reviews in Diagnostic Imaging 9, 51-76 (1977).
20. Newman P. E. The coronary collateral circulation. Determinants and functional significance in ischemic heart disease. Am Heart J 102, 431-435 (1981).
21. Weaver M. E., Pantely G. A., Bristow D J., et al. A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison widi oiher animals and man. Cardiovas Res 20, 907-917 (1986).
22. Hutchins G. M., Moore W G., Hatton E. V. Arterial-venous relationships in the human left ventricular myocardium: anatomic basis for counter current regulation of blood flow. Circulation 74, 1195-1202 (1986).
23. Gavin J. B., Maxwell L., Sage M. D. Interrelationships of ultrastructure and function in the micrnvasoulature of normal and ischaemic myocardium. Journal of Electron Microscopy Technique 19, 429-438 (1991).
24. Wiedeman M. P. Introduction. 1 n:Benchmark papers in human physiology; the microcirculation, edited by Wicdcman, M. P. Stroudsburg: Dowdcn, Hutchinson and Ross, p. 1 (1974).
25. Wells R. Microcirculation and coronary blood flow. Am J Cardiol 29, 847-850 (1972).
26. Lugwig G. Capillary pattern of the myocardium. Meth Achievm Exp Path 5, 238-271 (1971).
27. Basingthwaightk J. B., Yipintsoi T., Harvey R. B, Microvasculature of dog left ventricular myocardium. Microvasc Res 7, 229-249 (1974).
28. Gerdes M A., Callas G., Kastkn F. H. Difference in regional capillary distribution and myocyte sizes in normal and hypertrophic rat hearts. Am J Anat 156, 523-532 (1979).
29. Rakusan K., Moravee J, Hatt P Y. Regional capillary supply in the normal and hypertrophied rat heart. Microvasc Res 20, 319-326 (1980).
30. Vetterlein F., Dal Ri H., Schmidt G. Capillary density in rat myocardium during timed plasma staining. Am J Physiol 242, HI33-H141 (1982).
31. Camilleri J. P., Ossondo N. M., Joseph D., et al. Capillary perfusion patterns in reperfused ischemic subendocardial myocardium', experimental study using fluorescent dextran, Exp Mol Pathol 39, 89-99 (1983).
32. Forman M B, Puett D. W., Virmam R. Endothelial and myocardial injury during ischaemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol 13, 450-459 (1989).
33. Anversa P., Levicky V, Beghi C., et al. Morphometry of exercise-induccd right ventricular hypertrophy in the rat. Circ Res 52, 57-64 (1983).
34. Petty R. G., Pearson J. D. Endothelium - the axis of vascular health and disease. J Royal Coll Physici London 23, 92-102 (1989).
35. Kaiser L, Sparks H. V. Jr. Endothelial cells. Not just a cellophane wrapper. Arch Intern Med 147, 569-573 (1987).
36. Eajardo L. F, The complexity of endothelial cells, AmJ Clin Pathol 92, 241-250 (1989).
37. Gerlach E., Nees S., Becker B. F. The vascular endothelium; a survey of some newly evolving biochemical and physiological features. Basic Res Cardiol 80, 459-174 (1985).
38. Furchgott R. F. Role of endothelium in responses of vascular smooth muscle. Circ Res 53, 557-573 (1983).
39. Busse R., Trogisch G., Bassenge E. The role of endothelium in the control of vascular tone. Basic Res Cardiol 80, 475-90 (1985).
40. Luscher T. F., Richard V., Tschudi M., et al. Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 15, 519-527 (1990).
41. Henderson A. H. Endothelium in control. Br Heart J 65, 116-125 (1991).
42. Moncada S., Palmer R. M. J., Higgs E. G. Nitric-oxide: physiology, pathophysiology, and pharmacology. Pharmacol Reviews 43, 109-142 (1991).
43. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent constrictor peptide produced by vascular endothelial cells. Nature 332, 411-415 (1988).
44. Tippins J. R., Antonio J. W., Maseri A. Endothelin-1 is a potent constrictor in conductive and restrictive coronary arteries. J Cardiovasc Pharmacol 13 (Suppl 15), S177-S179 (1989).
45. + exchange. Circ Res 68, 269-279 (1991).
46. Harrison D. G. The endothelial cell. Heart Dis & Stroke I, 95-99.
47. Berne R. M. The role of adenosine in the regulation of coronary flow. Circ Res 47, 807-813 (1980).
48. 3 release during coronary occlusion and reperfusion. J Cardiovasc Pharmacol 6, 442-148 (1984).
49. Cronstein B. N., Levin R. I., Belanoef J., et al. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 78, 760-770 (1986).
50. Cronstein B. N., Kramer S. B., Weismann G., et al. Adenosine: a physiologic modulator of superoxide anion generation by human neutrophils. J Exp Med 158, 1160-1177 (1983).
51. Fielding P. E., Vlodawsky L., Gospodarowigz D., et al. Effect of contact inhibition on the regulation of cholesterol metabolism in cultured vascular endothelial cells. J Biol Chem 254, 749-755 (1979).
52. Nabel E. G. Biology of the impaired endothelium, AmJ Cardiol 68, 6C-8C (1991).
53. Rosenberg R. D., Rosenberg J. S. Natural anticoagulant mechanisms, J Clin Invest 74, 1-6 (1984).
54. Stern D., Brett J., Harris K., et al. Participation of endothelial cells in the protein C-protein S anticoagulant pathway; the synthesis and release of protein S. J Cell Biol 102, 1971-1978 (1986).
55. Ofosu F. A., Modi G. J., Smith L. M., et al. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Blood 64, 742-747 (1984).
56. Chesterman C. N. Vascular endothelium, hemostasis and thrombosis. Blood Rev 2, 88-94 (1988).
57. Levin E. C., Marzec U., Anderson J., et al. Thrombin stimulates tissue plasminogen activator release from culture human endothelial cells. J Clin Invest 74, 1988-1995 (1984).
58. Crossman D. C., Todenham E. D. G, Procoagulant functions of endothelium. In: The endothelium: an introduction to current research, edited by Warren, S. B. Wiley-Liss, Inc., pp. 119-128 (1990).
59. Harlan J. M. Leucocyte-endothelial interactions. Blood 65, 513-525 (1985).
60. Lawrence M. B., Springer T. A. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Ceil 65, 859-873 (1991).
61. Hattori R., Hamilton K. K., Fugate R. D., et al. Stimulated secretion of endothelial van Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 264, 7768-7771 (1989).
62. Ceng J G., Bevilacqua M. P., Logre K. L., et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-I40. Nature 343, 757-760 (1990).
63. Zimmerman G. A., Prescott S. M., McIntyre T. M. Endothelial cell interactions with granulocytes; tethering and signaling molecules. Immunology Today 13, 93-100 (1992).
64. Smith C. W., Rothlein R., Hughes B J. et al. Recognition of an endothelial determinant for GD-18-dcpendent human neutrophil adherence and transendothclial migration. J Clin Invest 82, 1746-1756 (1988).
65. Colditz I. G., Movat H. Z. Kinetics of neutrophil accumulation in acute inflammatory lesions induce by chemotaxins and chemotaxinogens. J Immunol 133, 2169-2173 (1984).
66. Bevilaccua M. P., Stengelin S., Gimbrone M. A., et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243, 1160-1164 (1989).
67. Gajdusek G., DiCorleto P., Ross R., et al. Art endothelial cell-derived growth factor, J Cell Biol 85, 467-472 (1980).
68. Gibbons G. H., Dzau V. J. Endothelial function in vascular remodelling. In: The endothelium: an introduction to current research, Wiley-Liss, Inc., pp. 81-93 (1990).
69. Castellotj J., Addonizo M. L., Rosenberg R., et al. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle growth. J Cell Biol 90, 372-379 (1981).
70. Garg U. C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured vascular smooth muscle cells. J Clin Invest 83, 1774-1777 (1989).
71. Casscells W. Smooth muscle cell growth factors. Prog Growth Factor Res 3, 177-206 (1991).
72. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restcnosis. Circulation 86, 723-729 (1992).
73. Krug A., De Rochemont A. V. M., Korb G. Blood supply of the myocardium after temporary coronary artery occlusion. Circ Res 19, 57-62 (1966).
74. Kloner R. A., Ganote C. E., Jennings R. B. The “no-reflow phenomenon after temporary coronary oeelusion in the dog. J Clin Invest 54, 1496-1508 (1974).
75. Gavin J. B., Humphrey S. M., Herdson P. B. The “no-rcflow” phenomenon in ischemic myocardium. Int Rev Exp Pathol 25, 361-383 (1983).
76. Reimfr K. A., Lowe J. E., Rasmussen M. M., et al. The wave from phenomenon of ischemic cell death. I. myocardial infarct size us duration of coronary occlusion in dogs. Circulation 56, 786-794 (1977).
77. Gavin J. B., Sfelye R. N., Nevalainex T. J., et al. The effect of ischaemia on the function and structure of the microvasculature of the myocardium. Pathol 10, 103-111 (1978).
78. Humphrey S. M., Gavinj B., Herdson P. B. The relationship ofischaemic contracture to vascular reperfusion in the isolated rat heart. J Mol Cell Cardiol 12, 1397-1406 (1980).
79. Schofer J., Montz R., Mathfy D. G. Scintigraphic evidence of the “no reflow” phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 5, 593-598 (1985).
80. Ito H., Tomooka T., Sakai N., et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of left ventricular function in anterior myocardial function. Circulation 85, 1699-1705 (1992).
81. Gavinj B., Nevalainen I. J., Seelye R. N., et al. An association between the onset of rigor and loss of vascular competence in early myocardial infarcts. Pathol 10, 219-225 (1978).
82. Humphrey S. M., Thomson R. W., Gavinj B. The efTect of an isovolumic left vemicle on the coronary vascular competence during reflow after global ischaemia in the rat heart. Circ Res 49, 784-791 (1981).
83. Humphrey S M, Gavinj B. Reversal of the “no reflow” phenomenon in globally ischemic hearts by ventricular dilatation. Pathol 17, 437-442 (1985).
84. Sage M. D., Gavinj B. Scanning electron microscopy of heart muscle frceze-dried from dimethylsulfoxidc for simultaneous demonstration of cell morphology and microvascular function. Stain Tcchnol 61, 261-267 (1986).
85. Sage D M., Gavinj B. Morphological identification offunclional capillaries in the myocardium. Anat Rec 208, 283-289 (1984).
86. Sage M. D., Gavinj, B. Microvascular function at the margins of early experimental myocardial infarcts in isolated rabbit hearts. Heart Vess 2, 81-86 (1986).
87. Kloner R. A., Alker K. J. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the “noreflow” phenomenon during coronary perfusion. Circulation 70, 513-521 (1984).
88. Hoffman J. I. E., Spaan J. A. E. Pressure-flow relations in the coronary circulation. Physiol Rev 70, 331-390 (1990).
89. Mawsonj B., Gavinj B., Herdson P. B. A comparison of the effects of ischaemia and of selective occlusion of capillaries and terminal arterioles on coronary reperfusion. Pathol 14, 369-373 (1982).
90. Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41, 19-25 (1977).
91. Parker P. E., Bashour F. A., Downey H. F., et al. Coronary hemodynamics during reperfusion following acute coronary ligation in dogs. Am Heart J 90, 593-599 (1975).
92. Gorman M. W., Sparks H. V. Progressive coronary vasoconstriction during relative ischemia in canine myocardium, Circ Res 51, 411-420 (1982).
93. Armiger L. C., GavinJ. B. Changes in the microvasculature of the ischemic and infarcted myocardium. Lab Invest 33, 51-56 (1975).
94. Maxwell L., Gavin J. B. The contribution ofischaemia to the development of microvascular incompetence in the myocardium. Cardiovasc Res 25, 491-495 (1991).
95. Maxwell L., Gavin J. B., Walker S. The oxygen content of the fixative is important in the interpretation of the ultrastructure of ischaemic myocardium. J Electron Micros Tech 17, 356-360 (1991).
96. Maxwell L., Gavin J. B. Antioxidant therapy improves microvascular ultrastructure and perfusion in post-ischaemic myocardium. Microvasc Res (In Press).
97. Van Reempts J., Haseldongkx M., Borgers M. A simple technique for the microscopic study of microvascular geometry and tissue perfusion allowing simultaneous histopathologic evaluation. Microvasc Res 25, 300-306 (1983).
98. Tilton R. G., Larson K B., Udell J R., et al. External detection of early microvascular dysfunction after “noflow” ischemia followed by reperfusion in isolated rabbit hearts. Circ Res 52, 210-225 (1983).
99. Sunnergren K. P., Rovetto M J. Myocyte and endothelial injury with ischemia rcpcrfusion in isolated rat hearts. Amj Physiol 252, H1211-H1217 (1987).
100. McDonagh P. F., Roberts D. J. Prevention of transcoronary macromolecular leakage after ischemia-reperfusion by the calcium entry blocker disoldipine. Circ Res 58, 127-136 (1986).
101. Dauber I. M., VanBenthuysen K. M., McMurty I F., et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res. 66, 986-998 (1990).
102. Reynolds J. M., McDonagh P. F. Early re perfusion, leukocytes alter perfused coronary capillarity and vascular resistance, Amj Physiol 257, H982-H989 (1989).
103. West P. N., Williamson J. R., Noraj D., et al. Reperfusion of ischemic myocardium: microvascular injury. Surg Forum 28, 246-247 (1977).
104. Mehta J. L., Nichols W W., Donnelly W H., et al. Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion-reperfusion. Circ Res 64, 43-54 (1989).
105. Engler R. L., Dahlgren M. D., Morris D. D., et al. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Amj Physiol 251, H314-H322 (1986).
106. Babbitt D. G., Virmani R., Forman B. M. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 80, 1388-1399 (1989).
107. Olafsson B., Forman M. B., Puett D W., et al. Reduction of reperfusion injury in the canine preparation by intraeoronary adenosine: import anee of the endothelium and the “no reflow” phenomenon. Circulation 76, 1 135-1145 (1987).
108. Forman M. B., Puett D W., Bingham S. E., et al. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in canine preparation of reperfusion. Circulation 76, 469-479 (1987).
109. Bajaj A. K., Cobb M. A., Virmani R., et al. Limitation of myocardial rcpcrfusion injury by intravenous perfluoro-chemicals: role of neutrophil activation. Circulation 79, 645-656 (1989).
110. Nichols W. W., Mehta J. L., Donnelly W. H., et al. Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins. J Mol Cell Cardiol 20, 943-954 (1988).
111. McFalls E. O., Duncker D. J., Krams R., et al. Endothelium dependent vasodilatation following brief ischaemia and reperfusion in anaesthetised swine. Cardiovasc Res 25, 659-665 (1991).
112. 7 reserve in stunned myocardium. Amj Physiol 256, H1303-H1310 (1989).
113. Laxson D. D., Homans D C., Dai X-Z., et al. Oxygen consumption and coronary reactvity in postischemic myocardium. Circ Res 64, 9-20 (1989).
114. Kirkeboen K. A., Aksnes G., Ilebekk A. Coronary reactivity in the porcine heart after short lasting myocardial ischaemia: effects of duration ofischaemia and myocardial stunning. Cardiovasc Res 24, 998-1007 (1990).
115. Kim Y. D., Fomsgaard J S., Heim K F., et al. Brief ischemia-reperfusion induces stunning of endothelium in canine coronary artery. Circulation 85, 1473-1482 (1992).
116. Ambrosio G., Weisman H. F., Mannisi J A, et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80, 1846-1861 (1989).
117. Is ao P. S., Lefer A. M. Time course and mechanism of endothelial dysfunction in isolated ischemic- and hvpoxic-perfused rat hearts. Amj Physiol 259, H1660-H1666 (1990).
118. Furghgott R F., Zawadski J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376 (1980).
119. Ku D. C. Coronary vascular reactivity after acutee myocardial ischemia. Science 218, 576-578 (1982).
120. VanBenthuysen K. M., McMurtry I. F., Horwitz L. D. Rcpcrfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetycholine and augments contractile reactivity in vitro. J Clin Invest 79, 265-274 (1987).
121. Sheridan F M., Dauber I M., McMurtry I. F., et al. Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion. Circ Res 69, 1566-1574 (1991).
122. Ma X-L., Tsao P. S., Viehman G E., et al. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res 69, 95-106 (1991).
123. Quillen J. E., Sellke F. W., Brooks L. A., et al. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 82, 586-594 (1990).
124. Mehta J. L., Lawson D. L., Nichols W W. Attenuated coronary relaxation after repcrfusion: effects oT supcroxidc dismutase and TxA., inhibitor U-63557. Am J Physiol 257, H1240-H1246 (1989).
125. Lefer A. M., Ma X-L. Endothelial dysfunction in the splanchnic circulation following ischemia and repcrfusion, J Cardiovasc Pharmacol 17 (Supple 3)*, S186-S190 (1991).
126. Dulon E., Owen P., Opie L. H. Altenualed rcperfusion stunning with a calcium channel antagonist or internal calcium blocker in the isolated perfused rat heart, j Mol Cell Cardiol 22, S38 (Abstract) (1990).
127. Kuroda H., Ishigur O S., Mori T. Optimal calcium concentration in the initial rc.perfusate for post-ischemic myocardial performance (calcium concentration during repcrfusion). J Mol Cell Cardiol 18, 625-633 (1986).
128. Kitakaze M., VVeisman H. F., Marban E. Contractile dysfunction and AFP depletion after transient calcium overload in perfused ferret hearts. Circulation 77, 685-695 (1988).
129. Heyndrickx G. R., Baig H, Nellens P., et al. Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 234. H653-H659 (1978).
130. Bolli R., Triana J. F. Jeroudi M. O. Prolonged impairment of coronary vasodilation after reversible ischemia, evidence for microvascular “stunning”. Circ Res 67, 332-343 (1990).
131. Nicklas J. M., Cips S. J. Decreased coronary flow reserve after transient myocardial ischemia in dogs. J ACC I, 195-199 (1989).
132. Pearson P. J., Schaff H. V., Vanhoutte P. M. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after rcperfusion injury in canine coronary arteries. Circulation 81, 1921-1927 (1990).
133. Shiki K., Hearse D. J. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. AmJ Physiol 253, HI470-H1476 (1987).
134. Murry C. E., Jennings R. B., Reimer K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136 (1986).
135. Hoffmeister H. M., Store R., Thiedemann K. U., et al. High-energy phosphates, myocardial contractile function and material properties after short periods of oxygen deficiency. Basic Res Cardiol 84, 77-90 (1989).
136. Stahl E. D., Avers ago T. R., Becker L. C. Selective enhancement of function of stunned myocardium by increased flow. Circulation 74, 843-851 (1986).
137. Tillmans H., Neumann F-J., Parkh N, et al. Prevention of microvascular disturbances in stunned myocardium by nifedipine. Circulation 78 (Suppl. II), 11-533 (Abstract) (1988).
138. Lamb F. S., King C. M., Harrell K., et al. Free radical-mediated endothelial damage in blood vessels after electrical stimulation. AmJ Physiol 252, H1041-H1046 (1987).
139. Todoki K., Okabf E., Kiyose T., et al. Oxygen free radical-mediated selective endothelial dysfunction in isolated coronary artery. AmJ Physiol 262, H806-H812 (1992).
140. Stewart D. J., Pohl U., Bassenge E. Free radicals inhibit endothelium-dependent dilation in the coronary resistance bed. AmJ Physiol 255, H765-H769 (1988).
141. Przyklenk K, Kloner R A. “Reperfusion injury” by oxygen-derived free radicals? Elicet of su peroxide dismutase plus catalasc, given at the time of repcrfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 64, 86-96 (1989).
142. Lefer A.M, Tsao P. S., Lefer D. J., et al. Role of endothelial dysfunction in the pathogenesis of rcperfusion injury after myocardial ischemia. FASEBJ, 2029-2034 (1991).
143. Cryglewski R. J., Palmer R. M. J., Moncada S. Supcroxidc anion is involved in the breakdown ofcndothcliurn-dcrived vascular relaxing factor. Nature 320, 454M-56 (1986).
144. Rubanyi G. M„ Vanhoutte P. M. Superoxide anions and hypcroxia inactivate endothclium-dcrivcd relaxing factor. AmJ Physiol 250, H822-H827 (1986).
145. Rubanyi G. M.Vanhoutte P. M. Oxygen-derived free radicals, endothelium and responsiveness of vascular smooth muscle. AmJ Physiol 250, H815-H821 (1987).
146. Saliminen K., Tikkanen I., Saijonmaa O, et al. Modulation of coronary tone in acute myocardial infarction by cndothelin. Lancet ii, 747-749 (1989).
147. Liu J. J., Chen D. J., Gasley D. J., et al. E fleet of ischemia and repcrfusion on ‘4 binding in rat cardiac membranes. AmJ Physiol 258, H829-H835 (1990).
148. Englkr R L, Schmid-Schonbein G. W., Pavelec R. S. Leukocyte capillary plugging In myocardial ischemia and rcperfusion in the dog. Am j Path 111, 98-111 (1983).
149. Entman M. L., Youker K., Shappell S. B., et al. Neutrophil adherence to isolated canine myocytes. J Clin Invest 85, 1497-1506 (1990).
150. Lugchesi B. R, VVerns S. W, Fantone J. C. The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol 21, 1241-1251 (1989).
151. Lugghesi B. R. Modulation of leukocyte-mediated myocardial rcperfusion injury. Am Rev Physiol 52, 561-576 (1990).
152. Fabiani J. N. The no-reflow phenomenon following early reperfusion of myocardial infarction and its prevention by various drugs. Hart Bulletin 7, 134-142 (1976).
153. Sghmid-Sghonbein C. YV., Engler R. L, Granulocytes as active participants in acute myocardial ischemia and infarction. AmJ Cardiovasc Pathol 1, 15-30 (1986).
154. Mullane K. M., Read N., Salmon J. A., et al. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp 'l'hcr 228, 510-522 (1984).
155. Romson J. L., Hook B. G., Kunkel S. L., et al. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67, 1016-1023 (1983).
156. Dk Logeril M., Basmadjiay A., Lavallee M. Influence of leukopenia on collateral flow, re perfusion flow, reflow ventricular fibrillation and infarct size in dogs. Am Heart J 117, 523-532 (1989).
157. Litt M. R., Jeremy R. W., Weisman H. F. et al. Neutrophil depletion limited to reperfusion r.educes myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated repcrfusion injury. Circulation 80, 1816-1827 (1989).
158. Mullane K. M., Young M. The contribution of neutrophil activation and changes in endothelial function to myocardial ischcmia-repcrfusion injury. In: Myocardial Protection: the pathophysiology of reperfusion and reperfusion injury, edited by Yellon D. M. and Jennings, R. B. New York: Raven Press, Ltd, pp. 59-83 (1992).
159. Johnson G., Furlan L. E., Aoki N., et al. Endothelium and myocardial protecting actions of laprostcne, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats. Circ. Res 66, 1362-1370 (1990).
160. Ohlstein E. H., Nichols A. J. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Cir Res 65, 917-924 (1989).
161. Nishida M., Kuzuya T., Hoshida S., et al. Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res 66, 253-258 (1990).
162. Mullane K. M., Moncada S. The salvage of ischemic myocardium by BW755C in anesthetized dogs. Prostaglandins 24, 255-266 (1982).
163. Palluy O., Morliere L., Gris J. G., et al. Hypoxia/reoxygenation stimulates endothelium to promote neutrophil adhesion. Free Rad Biol Med 13, 21-30 (1992).
164. Lipasti J. A., Alanen K. A., Nevelanan T. J. The effect of hypertonic mannitol on microvascular function in hypoxic and reoxygenated rat myocardium. Cardiovasc Res 16, 283-287 (1982).
165. Humphrey S. M., Gavin J. B., Armiger L. C. Changes in the contractile state, fine structure and metabolism of cardiac muscle cells during the development of rigor mortis. Virchows Arch (Cell Pathol) 35, 159-167 (1981).
166. Sawatarj K., Kadoba K., Bergner K. A., et al. Influence of initial reperfusion pressure after hypothermic cardioplegic ischemia on endothelial modulation of coronary tone in neonatal lambs: impaired coronary vasodilator response to acetylcholine. J Thorac Cardiovasc Surg 101, 777-782 (1991).
167. Kleber A. G. Extracellular potassium accumulation in acute myocardial ischaemia. J Mol Cell Cardiol 16, 389-394 (1984).
168. Hearse D. J., Braimbridge M. V., Jynge P. Protection of the ischemic myocardium: cardioplegia, New York: Raven Press, pp. 228-235 (1981).
169. Follette D. M., Buckberg G. D., Mulder G. D, et al. Deleterious effects of crystalloid cardioplegic solutions on arterial endothelial cells. Surg Forum 31, 25-28 (1980).
170. Harjula A., Mattila S., Mattila I., et al. Coronary endothelial damage after crystalloid cardioplegia. J Cardiovasc Surg 25, 147-152 (1984).
171. Harjula A., Mattila S., Myllarniemi H., et al. Effects of synthetic blood and crystalloid cardioplegic solutions on coronary endothelium: an experimental scanning electron microscope study. J Surg Res 39, 405-412 (1985).
172. Rosenbaum D., Levitsky S., Silverman N., et al. Cardioplegia does not prevent injury induced by intracoronary platelet deposition. Circulation 68 (Suppl II), 11.102-11.106 (1983).
173. Lindal S., Sorlie D., Jorgensen L. Endothelial cells of the cardiac microvasculature during and after cold cardioplegic ischaemia: comparison of endothelial and myocyte damage. Scand J Thor Cardiovasc Surg 22, 257-265 (1988).
174. Carfentier S., Murawsky M., Carpentier A, Cytotoxicity of cardioplegic solutions: evaluation of tissue culture. Circulation 64 (Suppl II), 11-90-11-95 (1981).
175. Chiavarelli R., Mauchiarelh G., Familiari G, et al. Ultrastructural changes of coronary artery endothelium induced by cardioplegic solutions, Thorac Cardiovasc Surgeon 37, 151-157 (1989).
176. Saldanha C., Hearse D, J. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. Possible evidence of endothelial damage. J Thorac Cardiovasc Surg 98, 783-787 (1989).
177. Nilsson F. N., Miller V M., Vanhoutte P. M., et al. Methods of cardiac preservation alter the function of the endothelium in porcine coronary arteries. J Thorac Cardiovasc Surg 102, 923-930 (1991).
178. Keller M. W., Geddes L., Spotnitz W., et al. Microcirculatory dysfunction following perfusion with hyperkalemic, hypothermic, cardioplegic solutions and blood repcrfusion. Circulation 84, 2485-2494 (1991).
179. Pelc L. R., Garancis J. C., Gross G. J., et al. Alteration of endothelium-dependent distribution of myocardial blood flow after coronary occlusion and reperfusion. Circulation 81, 1928-1937 (1990).
180. Pelc L. R., Gross G. J., Kampine J. P., et al. Mechanisms of enhanced canine subendocardial perfusion: a comparison of adenosine triphosphate and sodium nitroprussidc. Anesth Analg 67, 514-520 (1988).
181. Forman M. B., Virmani R. Pathogenesis and modification of myocardial reperfusion injury. In: Acute myocardial infarction, edited by Gersh, B. J. and Rahimtoola, S. H. New York: Elsevier, pp. 349-370 (1990).
182. Przyklenk K., Ghafari G. B., Eitzman D. T., et al. Nifedipine administered after repcrfusion ablates systolic contractile dysfunction of postischemic “stunned” myocardium. J Am Coll Cardiol 13, 1176-1183 (1989).
183. Hashimoto K., Pearson P. J., Schaff H. V., et al. Endothelial cell dysfunction after ischemic arrest and reperfusion: a possible mechanism of myocardial injurv during reflow. J Thorac Cardiovasc Surg 102, 688-694 (1991).